Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.

Publikation

Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial.

Wissenschaftlicher Artikel/Review - 17.04.2023

Sumer Johannes, Keckeis Karin, Scanferla Giulia, Frischknecht Manuel, Notter Julia, Steffen Ana, Kohler Philipp, Schmid Patrick, Roth Bianca, Wissel Kerstin, Vernazza Pietro L, Klein Peter, Schoop Roland, Albrich Werner

Zitation

Sumer J, Keckeis K, Scanferla G, Frischknecht M, Notter J, Steffen A, Kohler P, Schmid P, Roth B, Wissel K, Vernazza P, Klein P, Schoop R, Albrich W. Novel Echinacea formulations for the treatment of acute respiratory tract infections in adults-A randomized blinded controlled trial. Front Med (Lausanne) 2023; 10:948787.

Art

Wissenschaftlicher Artikel/Review (Englisch)

Zeitschrift

Front Med (Lausanne) 2023; 10

Veröffentlichungsdatum

17.04.2023

ISSN (Druck)

2296-858X

Seiten

948787

Kurzbeschreibung/Zielsetzung

has clinical antiviral activity against respiratory viruses and modulates immune functions. In this study, we compared higher doses of new formulations with conventional formulations at lower, preventive doses for therapy of respiratory tract infections (RTIs).